Decreased astrocytic GFAP expression in streptozotocininduced diabetes after gliotoxic lesion in the rat brainstem

10Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Objective: The aim of this study was to evaluate the effect of diabetic hyperglycemia on astrocyte function, estimated by means of glial fibrillary acidic protein - GFAP - immunohistochemical expression. Materials and methods: Adult male rats received a single intravenous injection of streptozotocin (50 mg/kg) and were submitted 10 days later to a single injection of 10 microlitres 0.1% EB solution or 0.9% saline solution into the cisterna pontis.Ten microliters of 0.1% EB or 0.9% saline solution were also injected in non-diabetic rats. Animals were anesthetized and perfused through the heart 15 and 31 days after EB or saline injection, and brainstem sections were collected for ultrastructural analysis and GFAP immunohistochemical staining. Results: The GFAP brown-stained areas were evaluated by colorimetry using a computerized image analysis system and the results have shown that diabetes hindered the increase of GFAP astrocyte expression in the EB-injected group compared to non-diabetic animals. However, diabetes did not affect GFAP response in the saline-injected group or in control animals. Conclusion: Streptozotocin-induced diabetic condition reduced astrocytic GFAP expression following gliotoxic injury. © ABE&M todos os direitos reservados.

Cite

CITATION STYLE

APA

Bondan, E. F., Martins, M. de F. M., & Viani, F. C. (2013). Decreased astrocytic GFAP expression in streptozotocininduced diabetes after gliotoxic lesion in the rat brainstem. Arquivos Brasileiros de Endocrinologia e Metabologia, 57(6), 431–436. https://doi.org/10.1590/S0004-27302013000600004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free